VIRP — Virbac SA Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapHigh Flyer

Annual income statement for Virbac SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

	2021 December 31st	R2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	1,064	1,216	1,247	1,397	1,465
Cost of Revenue
Gross Profit	709	790	810	938	975
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	896	1,037	1,063	1,180	1,239
Operating Profit	168	180	184	217	226
Total Net Non Operating Interest Income / Expense
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	159	176	174	208	218
Provision for Income Taxes
Net Income After Taxes	115	121	121	145	150
Minority Interest
Equity in Affiliates
Net Income Before Extraordinary Items
Net Income	113	122	121	145	151
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	113	122	121	145	151
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	13.5	14.8	14.5	18.3	18.4
Dividends per Share